Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function
Clinical trial NCT06004661 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06004661
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-04
- Primary completion
- 2026-12-14
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.